Focus Factor Original is a dietary supplement, not a verified treatment for memory loss, dementia, or Alzheimer's disease. Its ingredients, limited healthy-adult evidence, and roughly $0.80 standard daily cost do not establish that it improves diagnosed memory problems. The current Focus Factor product page states that the supplement is not intended to diagnose, treat, cure, or prevent disease, including Alzheimer's. Its only reported human trial involved healthy adults rather than people with memory loss or dementia.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What is in Focus Factor Original?
- What did the human trial find?
- Does the evidence apply to dementia or diagnosed memory loss?
- What safety questions should families ask?
- How much does the labeled regimen cost?
What is in Focus Factor Original?
A four-tablet serving contains a 640-milligram proprietary blend. Named ingredients include DMAE, bacopa, phosphatidylserine, DHA fish oil, GABA, vinpocetine, and huperzine A. The formula also contains numerous vitamins and minerals.
"Proprietary blend" means the label provides the blend's total weight but not each ingredient's dose. That prevents readers and clinicians from comparing individual amounts with those studied elsewhere or assessing each ingredient separately. A long ingredient list does not show that the combination treats memory loss. The relevant question is whether this exact formula and dose have produced meaningful benefits in people like the intended user.
What did the human trial find?
The manufacturer sponsored a 2011 randomized, double-blind, placebo-controlled trial at one center. It enrolled 96 healthy adults ages 18 through 65 who took four tablets daily for six weeks. The analysis included 89 participants considered compliant with the study.
Participants taking Focus Factor improved by 6.5 words on repeated verbal-list recall, compared with 4.5 words for placebo. At week six, baseline-adjusted totals were 51.9 and 49.7 words, respectively, with p=0.002, according to the manufacturer's clinical study report. That result reflects performance on a specific memory test. It does not demonstrate better daily functioning, safer medication management, or slower cognitive decline.
Does the evidence apply to dementia or diagnosed memory loss?
The trial does not establish a benefit for people with dementia, Alzheimer's, or diagnosed memory loss. It enrolled healthy adults and excluded significant medical or psychiatric disorders that could affect cognition. The tested population therefore differs from the people most likely to seek a memory-loss treatment. The study also lasted only six weeks and was designed and sponsored by the product's maker.
Sponsorship does not automatically invalidate a result, but the finding needs cautious interpretation because it lacks evidence from the target patient population. Advertising history provides additional context without proving whether the current formula works. In 2004, marketers settled FTC allegations that earlier memory, focus, concentration, and related claims lacked substantiation. The settlements required $1 million and $60,000 in consumer redress but were not admissions of violations, according to the Federal Trade Commission announcement.
What safety questions should families ask?
The label identifies fish and soy. It warns against use by pregnant women or women of childbearing age because the formula contains vinpocetine. People with medical conditions are advised to consult a physician.
Dietary supplements do not undergo FDA review for effectiveness before marketing. The FDA's consumer guidance also warns that supplement ingredients can change how medications are absorbed, metabolized, or removed from the body. Before use:.
- Bring the complete label and a list of medications and supplements to a clinician.
- Flag fish or soy concerns, pregnancy potential, and existing medical conditions.
- Ask whether any ingredient could interfere with current medicines.
- Define the intended benefit and how it would be assessed before paying for repeated bottles.
How much does the labeled regimen cost?
The product listing accessed August 13, 2026, priced a 150-tablet bottle at $29.99. The label directs adults to take four tablets daily, with an upper limit of eight.
These figures exclude tax and shipping. Before purchasing, compare the recurring cost with the central evidence gap: the six-week healthy-adult trial does not show that Focus Factor treats dementia or diagnosed memory loss.
- Four tablets daily: 37.5 days per bottle, about $0.80 daily or $24 per 30 days.
- Eight tablets daily: 18.75 days per bottle, about $1.60 daily or $48 per 30 days.
